1360 Treatment with a novel hexavalent OX40 agonist remodels the tumor microenvironment to favor anti-tumor immunity in mice

• William L Redmond,
• Melissa Kasiewicz,
• Annah Rolig,
• Yaiza Diaz De Durana,
• Rashi Yadav

Affiliations

William L Redmond

7Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA

Melissa Kasiewicz

1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA

Annah Rolig

1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA

Yaiza Diaz De Durana

3Inhibrx, La Jolla, CA, USA

Rashi Yadav

2Oregon Health and Science University, Portland, OR, USA